To improve access to care, many professional organizations have advocated for classifying obesity as a disease. However, the ...

Women and older adults taking the anti-obesity drug semaglutide may be at higher risk for muscle loss, but higher protein ...

The anti-obesity medication tirzepatide, marketed as Mounjaro for diabetes and Zepbound for obesity, reduced ...

A new study has made the case for synching your daily calories with your own circadian rhythm to improve glucose metabolism, ...

Obesity isn’t just a global problem - it’s hitting Singapore hard. In 2022, nearly 12 out of every 100 adults were obese - ...

For many years, health experts have been concerned about "food deserts," places where residents lack good nutritional options ...

For many people, weight loss is often framed as a matter of willpower – a simple equation of exercising regularly and eating a healthy diet. But, Dr. Sindhura Bandaru, an ...

Using tirzepatide and menopause hormone therapy at the same time leads to increased weight loss in postmenopausal women with ...

An oral melanocortin-4 receptor agonist conferred significant BMI reductions among adolescents and adults with hypothalamic ...

Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging ...

Adults with obesity were more likely to achieve a 10% or greater weight loss at 1 year if they continued using their ...

About 1 in 5 classified as overweight based on BMI alone considered to have obesity according to European society definition.